Julia Marie Eastland - Nov 8, 2021 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
President and CEO, Director
Signature
/s/ Julie Eastland by Laura Berezin, Attorney-in-Fact
Stock symbol
HARP
Transactions as of
Nov 8, 2021
Transactions value $
$0
Form type
4
Date filed
11/9/2021, 03:02 PM
Previous filing
Jun 4, 2021
Next filing
May 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Stock Option (Right to Buy) Award $0 +350K $0.00 350K Nov 8, 2021 Common Stock 350K $6.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, November 8, 2022, and the remaining seventy-five percent shall vest over the following three years in equal monthly installments.